Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW)

CUSIP: 76155X118

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / *W EXP 12/17/202
Total 13F shares
7,607,269
Share change
+2,937,203
Total reported value
$1,314,887
Price per share
$0.18
Number of holders
20
Value change
+$528,254
Number of buys
5
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 76155X118?
CUSIP 76155X118 identifies RVMDW - Revolution Medicines, Inc. - *W EXP 12/17/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) as of Q4 2024

As of 31 Dec 2024, Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,607,269 shares. The largest 10 holders included LMR Partners LLP, D. E. Shaw & Co., Inc., PRICE T ROWE ASSOCIATES INC /MD/, ADAGE CAPITAL PARTNERS GP, L.L.C., SOROS CAPITAL MANAGEMENT LLC, Walleye Capital LLC, ARISTEIA CAPITAL, L.L.C., PERCEPTIVE ADVISORS LLC, Bleichroeder LP, and Sculptor Capital LP. This page lists 20 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.